The US Food and Drug Administration kicked off enforcement of facility and product registration requirements of the Modernization of Cosmetics Regulation Act in July, though stakeholders have generally not received enforcement letters or faced agency action so far, says attorney Angela Diesch of Amin Wasserman Gurnani, LLP.
FDA Issuing Facility Inspection Requests Under MoCRA, While Slow On Enforcement (So Far)
The US FDA has generally not sent out enforcement letters to stakeholders of the Modernization of Cosmetics Regulation Act, but that doesn’t mean it’s not happening, says Amin Wasserman Gurnani, LLP attorney Angela Diesch, during a 19 November webinar hosted by Global Victoria, the trade facilitation agency for the state of Victoria in Australia.
